Cargando…
Efficacy of daily GnRH agonist for luteal phase support following GnRH agonist triggered ICSI cycles versus conventional strategy: A Randomized controlled trial
OBJECTIVE: The use of gonadotropin-releasing hormone agonist (GnRHa) as an alternative for human chronic gonadotropin (hCG) trigger has potential benefits, but the optimal luteal phase support (LPS) following GnRHa trigger remains to be elucidated. We aimed to investigate a new strategy (daily GnRH...
Autores principales: | Salehpour, Saghar, Nazari, Leila, Hosseini, Sedighe, Azizi, Elham, Borumandnia, Nasrin, Hashemi, Teibeh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Brazilian Society of Assisted Reproduction
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8312295/ https://www.ncbi.nlm.nih.gov/pubmed/33507722 http://dx.doi.org/10.5935/1518-0557.20200077 |
Ejemplares similares
-
Comparison of GnRH agonist versus luteal estradiol
GnRH antagonist protocol using transdermal testosterone in poor
responders
por: Fàbregues, Francesc, et al.
Publicado: (2019) -
Severe early ovarian hyperstimulation syndrome following GnRH agonist
trigger and freeze-all strategy in GnRH antagonist protocol; case report and
literature review
por: Hajizadeh, Nazanin, et al.
Publicado: (2023) -
Impact of Mid-Luteal Phase GnRH Agonist Administration on Reproductive Outcomes in GnRH Agonist-Triggered Cycles: A Randomized Controlled Trial
por: Benmachiche, Abdelhamid, et al.
Publicado: (2017) -
Comparison of GnRH Agonist, GnRH Antagonist, and GnRH Antagonist Mild Protocol of Controlled Ovarian Hyperstimulation in Good Prognosis Patients
por: Stimpfel, Martin, et al.
Publicado: (2015) -
GnRH agonist versus GnRH antagonist in assisted reproduction cycles: oocyte morphology
por: Cota, Ana Marcia M, et al.
Publicado: (2012)